These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 16393460

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Mechanisms of action of transportation of liposomes and chitosan-coated liposomes containing leuprolide across intestine and Caco-2 cell].
    Guo JX, Ping QN, Dong J, Li ZR, Li CJ.
    Yao Xue Xue Bao; 2005 Jan; 40(1):65-70. PubMed ID: 15881330
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Intranasal mucoadhesive buspirone formulation: in vitro characterization and nasal clearance studies.
    Khan SA, Patil KS, Yeole PG.
    Pharmazie; 2008 May; 63(5):348-51. PubMed ID: 18557417
    [Abstract] [Full Text] [Related]

  • 28. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin.
    Hintzen F, Perera G, Hauptstein S, Müller C, Laffleur F, Bernkop-Schnürch A.
    Int J Pharm; 2014 Sep 10; 472(1-2):20-6. PubMed ID: 24879935
    [Abstract] [Full Text] [Related]

  • 29. Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide.
    Carafa M, Marianecci C, Annibaldi V, Di Stefano A, Sozio P, Santucci E.
    Int J Pharm; 2006 Nov 15; 325(1-2):155-62. PubMed ID: 16884870
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Safety and clinical efficacy of a new 6-month depot formulation of leuprorelin acetate in patients with prostate cancer in Europe.
    Tunn UW, Wiedey K.
    Prostate Cancer Prostatic Dis; 2009 Nov 15; 12(1):83-7. PubMed ID: 19030021
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
    Wang X, Chi N, Tang X.
    Eur J Pharm Biopharm; 2008 Nov 15; 70(3):735-40. PubMed ID: 18684400
    [Abstract] [Full Text] [Related]

  • 36. Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part I. Influence of formulation variables on drug absorption in anesthetized rats.
    Zaki NM, Awad GA, Mortada ND, Abd ElHady SS.
    Int J Pharm; 2006 Dec 11; 327(1-2):89-96. PubMed ID: 16942844
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation.
    El-Samaligy MS, Afifi NN, Mahmoud EA.
    Int J Pharm; 2006 Feb 03; 308(1-2):140-8. PubMed ID: 16356669
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.